510(k) · Cleared
ClearedDimension Vista A1AT Flex Reagent Cartridge and Protein 1 Calibrator and Control Medium and High
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Dade Behring, Inc. · DEM Alpha-1-Antitrypsin, Antigen, Antiserum, Control
Cleared on Jan 11, 2007 as substantially equivalent to K053072 (Dade Behring, Inc., 2006) and 2 other predicates after a 38-day review. Its family tree reaches back 2 generations to 2000.
- Decided
- Jan 11, 2007
- Review
- 38 days
- Class
- Class II
- Product code
- DEM
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 2 generations to K002852 (2000). 6 ancestors in all, the oldest K860894 (1986). No later device cites it as a predicate yet.
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K002852 | N/T Protein Control SL | Dade Behring, Inc. | 2000 | — |
| −1 | K012468 | Modification to N/T Protein Control SL | Dade Behring, Inc. | 2001 | — |
| 0 (this device) | K063610 | Dimension Vista A1AT Flex Reagent Cartridge and Protein 1 Calibrator and… | Dade Behring, Inc. | 2007 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1986 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2006 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DEM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K053072 | N Antisera to Human ALPHA1-AntitrypsinSummary page 1…Immunology (82) and Clinical Chemistry (75) 3. Identification of the Legally Marketed Devices: Dade Behring NAntisera to Human al-Antitrypsin- K053072 Dade Behring N Protein Standard SL - K012470 Dade Behring N/T Protein Control SL - K012468… | 2006 |
| * | K012470 | Modification to N Protein Standard SLSummary page 1…. Identification of the Legally Marketed Devices: Dade Behring NAntisera to Human al-Antitrypsin- K053072 Dade Behring N Protein Standard SL - K012470 Dade Behring N/T Protein Control SL - K012468 j[t. AL 4. Device Descriptio… | 2001 |
| * | K012468 | Modification to N/T Protein Control SLSummary page 1…Dade Behring NAntisera to Human al-Antitrypsin- K053072 Dade Behring N Protein Standard SL - K012470 Dade Behring N/T Protein Control SL - K012468 j[t. AL 4. Device Descriptions: Dimension Vista'" AlAT Flex® reagent cartridge… | 2001 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 7 years and passes through 1 company; a new generation was cleared every 5.4 years on median.
- 1 of the 6 ancestors has a recall of any class.
- 1 other device also cites its predicate K053072.
How does its category compare?
All DEM devicesDEM Alpha-1-Antitrypsin, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · DEM
1in 2013
2026 to Oct 25, outlined.
Median 510(k) review, days · DEM
Too few DEM 510(k)s in any year since 2007 to give a median.
Recalls per year · DEM
1in 2017
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · DEM
1in 2024
MAUDE reports naming product code DEM, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 1 |
| 2012 | 0 | — | 0 | 1 |
| 2013 | 1 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 1 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 1 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 1 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The A1AT method is an in vitro diagnostic test for the quantitative determination of a 1-antitrypsin in human serum, heparinized plasma or EDTA plasma on the Dimension Vista® System. Measurements of ai-antitrypsin aid in the diagnosis of cirrhosis of the liver and pulmonary emphysema. PROT1 CAL is an in vitro diagnostic product for the calibration of the al-antitrypsin (AIAT), C3 Complement (C3), C4 Complement (C4), Immunoglobulin A (IGA), Immunoglobulin…
Read the full statement (131 words)
The A1AT method is an in vitro diagnostic test for the quantitative determination of a 1-antitrypsin in human serum, heparinized plasma or EDTA plasma on the Dimension Vista® System. Measurements of ai-antitrypsin aid in the diagnosis of cirrhosis of the liver and pulmonary emphysema.
PROT1 CAL is an in vitro diagnostic product for the calibration of the al-antitrypsin (AIAT), C3 Complement (C3), C4 Complement (C4), Immunoglobulin A (IGA), Immunoglobulin G (IGG), Immunoglobulin M (IGM), and Prealbumin (PREALB) methods on the Dimension Vista® System.
PROT1 CON L, M and H are assayed intralaboratory quality controls for assessment of precision and analytical bias in the determination of al-antitrypsin (AlAT), C3 Complement (C3), C4 Complement (C4), immunoglobulin A (IGA), immunoglobulin G (IGG2 , immunoglobulin M (IGM), and prealbumin (PREALB) on the Dimension Vista System.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K063610 · printed Nov 4, 2026
Cite this page
510(k) Report. “K063610: Dimension Vista A1AT Flex Reagent Cartridge and Protein 1 Calibrator and Control Medium and High.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K063610
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026